Skip to main navigation Skip to search Skip to main content

Both MRI and HAQ-DI can predict relapses following all treatment withdrawal in MTX-NAÏVE patients with RA in remission after 12 months of abatacept therapy in the avert trial

H. Ahmad, J. Baker, Mikkel Østergaard, P. Emery, T. Huizinga, J. Ye, S. Banerjee, P. Conaghan

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume76
Issue numberSuppl 2
Pages (from-to)240
Number of pages1
ISSN0003-4967
Publication statusPublished - 2017

Cite this